PMID: 6162157Dec 20, 1980Paper

Conformational alteration of mRNA structure and the posttranscriptional regulation of erythromycin-induced drug resistance

Nucleic Acids Research
T J GryczanD Dubnau

Abstract

The DNA sequence of the ermC gene of plasmid pE194 is presented. This determinant is responsible for erythromycin-induced resistance to the macrolide-lincosamide-streptogramin B group of antibiotics and specifies a 29,000 dalton inducible protein. The locations of the ermC promoter, as well as that of a probable transcriptional terminator, are established both from the sequence and by transcription mapping. The sequence contains an open reading frame sufficient to encode the previously identified 29,000 dalton ermC protein. Between the promoter and the putative ATG start codon is a 141 base pair leader sequence, within which several regulatory (constitutive) mutations have been mapped and sequenced. The leader has a second open reading frame, sufficient to encode a 19 amino acid peptide. It is suggested that induction by erythromycin involves a shift between alternative ribosome-bound mRNA conformations, so that the ribosome binding sequence and the start codon for synthesis of the 29K protein are unmasked in the presence of inducer. Possible active and inactive folded configuration of the leader sequence are presented, as well as the effects on these configurations of regulatory mutations.

References

Nov 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·G K McMaster, G G Carmichael
Jan 1, 1979·Annual Review of Genetics·M Rosenberg, D Court
Nov 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·C Talkington, J Pero
Apr 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·J F Gardner
Sep 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·G ZurawskiC Yanofsky
Sep 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·P P Di NoceraC B Bruni
Sep 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·W M Barnes
Dec 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·G ZurawskiC Yanofsky
Oct 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·R M GemmillJ M Calvo
Dec 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·J C AlwineG R Stark
Mar 1, 1978·FEBS Letters·F Sanger, A R Coulson
Mar 6, 1975·Nature·J Shine, L Dalgarno
Mar 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·T ManiatisD G Kleid
Apr 1, 1974·Proceedings of the National Academy of Sciences of the United States of America·J Shine, L Dalgarno
Apr 1, 1971·Proceedings of the National Academy of Sciences of the United States of America·C J Lai, B Weisblum
Jul 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·A G ShivakumarD Dubnau
Jan 1, 1980·Molecular & General Genetics : MGG·A G ShivakumarD Dubnau

❮ Previous
Next ❯

Citations

Jan 1, 1983·Molecular & General Genetics : MGG·J KreftW Goebel
Jan 1, 1982·Molecular & General Genetics : MGG·J HahnD Dubnau
Jan 1, 1985·Molecular & General Genetics : MGG·T Grundström, S Normark
Jan 1, 1984·Molecular & General Genetics : MGG·T J GryczanD Dubnau
Aug 1, 1989·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M Reig, F Baquero
Jun 15, 2011·Proceedings of the National Academy of Sciences of the United States of America·Nora Vázquez-LaslopAlexander S Mankin
May 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·F BaranyA Tomasz
Dec 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·J L Rosner
Dec 20, 1994·Proceedings of the National Academy of Sciences of the United States of America·K L HerbstR B Weiss
Feb 1, 1986·Journal of Biomolecular Structure & Dynamics·V BrendelE N Trifonov
Jan 19, 2012·Antimicrobial Agents and Chemotherapy·Ilya A OstermanOlga A Dontsova
Mar 1, 1995·Antimicrobial Agents and Chemotherapy·B Weisblum
Apr 1, 1995·Antimicrobial Agents and Chemotherapy·B Weisblum
Jun 16, 2001·Antimicrobial Agents and Chemotherapy·A E RosatoK A Nash
Jan 16, 2007·Clinical Microbiology Reviews·Florence DepardieuPatrice Courvalin
Mar 5, 2004·Journal of Bacteriology·Jeremy M YarwoodE Peter Greenberg
Jun 10, 2003·Microbiology and Molecular Biology Reviews : MMBR·Ciarán Condon
Sep 27, 2003·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Kimiko UbukataKeisuke Sunakawa
Jun 12, 2013·Annual Review of Biochemistry·Koreaki Ito, Shinobu Chiba
Feb 18, 2016·Nature Chemical Biology·Diego A Alonzo, T Martin Schmeing
Jan 5, 2016·Nature Chemical Biology·Pulkit GuptaNora Vázquez-Laslop
Feb 15, 2001·Expert Opinion on Investigational Drugs·G Bonfiglio, P M Furneri

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.